{
  "resourceType": "ValueSet",
  "id": "omop-concept-set-36",
  "url": "https://workbench.phema.science/fhir/ValueSet/omop-concept-set-36",
  "status": "active",
  "name": "Sodium Channel Blocking Drugs",
  "publisher": "PhEMA Workbench OMOP Concept Set Transformer",
  "compose": {
    "include": [
      {
        "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
        "concept": [
          {
            "code": "4441",
            "display": "flecainide"
          },
          {
            "code": "8754",
            "display": "propafenone"
          },
          {
            "code": "6926",
            "display": "mexiletine"
          },
          {
            "code": "6387",
            "display": "lidocaine"
          },
          {
            "code": "9068",
            "display": "quinidine"
          },
          {
            "code": "8700",
            "display": "procainamide"
          },
          {
            "code": "3541",
            "display": "disopyramide"
          },
          {
            "code": "703",
            "display": "amiodarone"
          },
          {
            "code": "5691",
            "display": "imipramine"
          },
          {
            "code": "704",
            "display": "amitriptyline"
          },
          {
            "code": "6448",
            "display": "lithium"
          },
          {
            "code": "42368",
            "display": "encainide"
          },
          {
            "code": "40169",
            "display": "moricizine"
          },
          {
            "code": "9071",
            "display": "quinine"
          },
          {
            "code": "3247",
            "display": "desipramine"
          },
          {
            "code": "8785",
            "display": "propoxyphene"
          },
          {
            "code": "42359",
            "display": "tocainide"
          }
        ]
      }
    ]
  }
}
